| 000 | 01079 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513205039.0 | ||
| 264 | 0 | _c20000516 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0738-081X | ||
| 024 | 7 |
_a10.1016/s0738-081x(99)00111-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTüzün, B | |
| 245 | 0 | 0 |
_aOral disorders: unapproved treatments or indications. _h[electronic resource] |
| 260 |
_bClinics in dermatology _c |
||
| 300 |
_a197-200 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aDermatologic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMouth Diseases _xdiagnosis |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aTüzün, Y | |
| 700 | 1 | _aWolf, R | |
| 773 | 0 |
_tClinics in dermatology _gvol. 18 _gno. 2 _gp. 197-200 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0738-081x(99)00111-x _zAvailable from publisher's website |
| 999 |
_c10696054 _d10696054 |
||